| Literature DB >> 35940589 |
Severino Jefferson Ribeiro da Silva1,2, Jessica Catarine Frutuoso do Nascimento1, Renata Pessôa Germano Mendes1, Klarissa Miranda Guarines1, Caroline Targino Alves da Silva1, Poliana Gomes da Silva1, Jurandy Júnior Ferraz de Magalhães1,3,4,5, Justin R J Vigar2, Abelardo Silva-Júnior6, Alain Kohl7, Keith Pardee2,8, Lindomar Pena1.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan, China, causing a respiratory disease called coronavirus disease 2019 (COVID-19), which has massively impacted global public health and caused widespread disruption to daily life. The crisis caused by COVID-19 has mobilized scientists and public health authorities across the world to rapidly improve our knowledge about this devastating disease, shedding light on its management and control, and spawned the development of new countermeasures. Here we provide an overview of the state of the art of knowledge gained in the last 2 years about the virus and COVID-19, including its origin and natural reservoir hosts, viral etiology, epidemiology, modes of transmission, clinical manifestations, pathophysiology, diagnosis, treatment, prevention, emerging variants, and vaccines, highlighting important differences from previously known highly pathogenic coronaviruses. We also discuss selected key discoveries from each topic and underline the gaps of knowledge for future investigations.Entities:
Keywords: SARS-CoV-2; clinical features; diagnosis; pathophysiology; prevention; reservoir hosts; transmission; treatment; vaccines; variants
Mesh:
Year: 2022 PMID: 35940589 PMCID: PMC9380879 DOI: 10.1021/acsinfecdis.2c00204
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.578